Skip to main content

Biolife Solutions(BLFS-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low17.86
Day High19.56
Open:18.27
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

Top Stories: Biolife Solutions

Select a category then submit the form to load news
Tipranks
BioLife Solutions Earnings Call Signals Profitable Growth
Tipranks
Maxim Group Sticks to Their Buy Rating for BioLife Solutions (BLFS)
Tipranks
BioLife Solutions Highlights Growth and Strategic Refocus in Presentation
Tipranks
Northland Securities Sticks to Its Buy Rating for BioLife Solutions (BLFS)
Tipranks
Lake Street Reaffirms Their Buy Rating on BioLife Solutions (BLFS)
Tipranks
Analysts Offer Insights on Healthcare Companies: Tectonic Therapeutic (TECX) and BioLife Solutions (BLFS)
Tipranks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Phathom Pharmaceuticals (PHAT), BioLife Solutions (BLFS) and RxSight (RXST)
Motley Fool
Relay Therapeutics Stock Up 235% This Past Year as One Fund Lifts Bet to $110 Million
Motley Fool
Structure Therapeutics Stock Surges 200% This Past Year as One Fund Cuts Stake by $15.5 Million
Motley Fool
BioLife (BLFS) Q4 2025 Earnings Call Transcript
Tipranks
Analysts Offer Insights on Healthcare Companies: BioLife Solutions (BLFS), Alkermes (ALKS) and Summit Therapeutics (SMMT)
Tipranks
Analysts Offer Insights on Healthcare Companies: NeurAxis, Inc. (NRXS), Janux Therapeutics Inc (JANX) and BioLife Solutions (BLFS)
Tipranks
Analysts Are Bullish on Top Healthcare Stocks: BioLife Solutions (BLFS), CVRx (CVRX)
Tipranks
BioLife Solutions (BLFS) Receives a Buy from Lake Street
Tipranks
Northland Securities Keeps Their Buy Rating on BioLife Solutions (BLFS)
Tipranks
Northland Securities Sticks to Its Buy Rating for BioLife Solutions (BLFS)
Tipranks
BioLife Solutions announces planned retirement of key executive
Tipranks
BioLife Solutions (BLFS) Gets a Buy from Northland Securities
Tipranks
Analysts Offer Insights on Healthcare Companies: Xenon (XENE), BioLife Solutions (BLFS) and Eli Lilly & Co (LLY)
Tipranks
Analysts Offer Insights on Healthcare Companies: Xenon (XENE) and BioLife Solutions (BLFS)
Motley Fool
BioLife Solutions' CFO Sells 30,000 Shares
Tipranks
BioLife Solutions Highlights Financial Performance in Presentation
Tipranks
Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX), BioLife Solutions (BLFS) and Cardiff Oncology (CRDF)
Motley Fool
BioLife (BLFS) Q3 2025 Earnings Call Transcript
Tipranks
Northland Securities Reaffirms Their Buy Rating on BioLife Solutions (BLFS)
Tipranks
Lake Street Reaffirms Their Buy Rating on BioLife Solutions (BLFS)
Tipranks
BioLife Solutions Reports Strong Q3 2025 Growth
Tipranks
Craig-Hallum Remains a Buy on BioLife Solutions (BLFS)
Tipranks
Craig-Hallum Sticks to Their Buy Rating for BioLife Solutions (BLFS)
Tipranks
BioLife Solutions (BLFS) Gets a Buy from Northland Securities
Tipranks
BioLife Solutions (BLFS) Receives a Buy from Jefferies
Tipranks
Analysts Offer Insights on Healthcare Companies: ClearPoint Neuro (CLPT), BioLife Solutions (BLFS) and Viking Therapeutics (VKTX)

Profile

BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.